secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bath & Body Works, Inc. (BBWI)
CIK:        0000701985
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001193125-23-193471
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bath & Body Works appoints Eva Boratto as CFO effective August 1, 2023
----------------------------------------------------------------------

- Eva Boratto named CFO, succeeds Wendy Arlin who steps down July 29, 2023.
- Boratto most recently CFO of Opentrons Labworks; earlier EVP & CFO of CVS Health.
- Base salary $850,000; target cash incentive 120% of salary; initial equity award $2.75M.
- Receives sign-on RSUs valued at $2.0M and cash sign-on bonus of $1.0M.
- Boratto has over 30 years of finance experience, including 20 years at Merck.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/701985/000119312523193471/0001193125-23-193471-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/701985/000119312523193471/d445921d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-193471

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer